AU8478601A - Methods for culturing human lung mast cells and uses thereof - Google Patents

Methods for culturing human lung mast cells and uses thereof

Info

Publication number
AU8478601A
AU8478601A AU8478601A AU8478601A AU8478601A AU 8478601 A AU8478601 A AU 8478601A AU 8478601 A AU8478601 A AU 8478601A AU 8478601 A AU8478601 A AU 8478601A AU 8478601 A AU8478601 A AU 8478601A
Authority
AU
Australia
Prior art keywords
human lung
lung mast
methods
cells
mast cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8478601A
Inventor
Edward S Schulman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philadelphia Health and Education Corp
Original Assignee
Philadelphia Health and Education Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Health and Education Corp filed Critical Philadelphia Health and Education Corp
Publication of AU8478601A publication Critical patent/AU8478601A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Abstract

Methods for culturing human lung mast cells in the absence of co-culture with feeder cells which are viable for longer than 4 days are provided. Also provided are methods for using these human lung mast cell cultures to assess biological and pharmacological activities of these cells in vivo and to identify modulators of the survival, proliferation, function and phenotypic expression of human lung mast cells. Modulators identified via these cells are useful in the prevention and treatment of diseases involving human lung mast cell function.
AU8478601A 2000-08-08 2001-08-08 Methods for culturing human lung mast cells and uses thereof Pending AU8478601A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22380700P 2000-08-08 2000-08-08
PCT/US2001/025033 WO2002012448A1 (en) 2000-08-08 2001-08-08 Methods for culturing human lung mast cells and uses thereof

Publications (1)

Publication Number Publication Date
AU8478601A true AU8478601A (en) 2002-02-18

Family

ID=22838046

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001284786A Ceased AU2001284786B2 (en) 2000-08-08 2001-08-08 Methods for culturing human lung mast cells and uses thereof
AU8478601A Pending AU8478601A (en) 2000-08-08 2001-08-08 Methods for culturing human lung mast cells and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001284786A Ceased AU2001284786B2 (en) 2000-08-08 2001-08-08 Methods for culturing human lung mast cells and uses thereof

Country Status (8)

Country Link
US (2) US7524679B2 (en)
EP (1) EP1315793B1 (en)
JP (1) JP2004505626A (en)
AT (1) ATE384121T1 (en)
AU (2) AU2001284786B2 (en)
CA (1) CA2419062A1 (en)
DE (1) DE60132466T2 (en)
WO (1) WO2002012448A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2009135001A2 (en) * 2008-04-30 2009-11-05 University Of Pittsburgh- Commonwealth System Of Higher Education Methods and compositions for regulating th2 and th17 responses
CN108865975B (en) * 2018-07-16 2021-11-23 浙江普罗亭健康科技有限公司 Plaque tissue digestion kit and application thereof
CN109852575A (en) * 2018-12-27 2019-06-07 河北生命原点生物科技有限公司 A kind of separation method of alveolar type II cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4117054B2 (en) * 1998-01-14 2008-07-09 信 川井 Antibody and production method thereof, fused cell producing this antibody and production method thereof, and antigen protein recognized by this antibody
US6080747A (en) * 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
JP4710846B2 (en) * 2007-02-21 2011-06-29 トヨタ自動車株式会社 Exhaust gas purification device for internal combustion engine
DE102008036127A1 (en) * 2008-08-01 2010-02-04 Emitec Gesellschaft Für Emissionstechnologie Mbh Method for operating an exhaust system with lambda control
US8474247B2 (en) * 2009-03-18 2013-07-02 GM Global Technology Operations LLC Particulate filter regeneration post-injection fuel rate control

Also Published As

Publication number Publication date
DE60132466T2 (en) 2008-12-24
JP2004505626A (en) 2004-02-26
ATE384121T1 (en) 2008-02-15
US20040014208A1 (en) 2004-01-22
WO2002012448A1 (en) 2002-02-14
DE60132466D1 (en) 2008-03-06
US7524679B2 (en) 2009-04-28
US20090176880A1 (en) 2009-07-09
EP1315793B1 (en) 2008-01-16
AU2001284786B2 (en) 2006-04-27
EP1315793A1 (en) 2003-06-04
EP1315793A4 (en) 2004-07-14
CA2419062A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
WO2001036589A3 (en) Human ex vivo immune system
GB2434157A (en) Platelets from stem cells
CA2388811A1 (en) Techniques for growth and differentiation of human pluripotent stem cells
WO2003014313A3 (en) Alternative compositions and methods for the culture of stem cells
DK1115840T3 (en) Progeny-specific cells and progenitor cells
BR0210599A (en) Use of carbon monoxide, method for maintaining an animal cell in vitro, article of manufacture as well as sterile cell medium
GB2393734A (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
WO2003065999A3 (en) Proliferated cell lines and uses thereof
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
GB0704640D0 (en) Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
WO2004076647A3 (en) Use of steady-state oxygen gradients to modulate animal cell functions
AU2003304250A1 (en) Method of isolating cells from umbilical cord
GB2427874A (en) Differentiation of stem cells to endoderm and pancreatic lineage
WO2003016507A3 (en) Generation of multipotent central nervous system stem cells
DK1242578T3 (en) Cell culture medium containing growth factors and L-glutamine
AU2002303437A1 (en) Isolation of neural stem cells using gangliosides and other surface markers
HK1076294A1 (en) Procedure for the large-scale t-lymphocytes culture in a homogeneous system
HK1070671A1 (en) Cotton rat lung cells for virus culture
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
DE69738822D1 (en) NEW BAC1-W MAMMAL, WHICH BELONGS TO THE BC1-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
IL146933A0 (en) Detachment surface
NZ508602A (en) The production of primmorphs from disassociated cells of sponges, corals and other invertebrates, and use thereof
WO2003029432A3 (en) Human mesenchymal progenitor cell
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells